Patients carrying a pathogenic RBM20 mutation and experimental models with loss of Rbm20
Patients with a TTN mutation
Ventricular arrhythmias and proarrhythmic Ca2+ releases from the sarcoplasmic reticulum
RBM20 mutations cause arrhythmogenic dilated cardiomyopathy via disturbed calcium handling, suggesting a potential therapeutic role for L-type calcium channel blockers.
We show that loss of Rbm20 disturbs Ca2+ handling and leads to more proarrhythmic Ca2+ releases from the sarcoplasmic reticulum. Patients that carry a pathogenic RBM20 mutation have more ventricular arrhythmias despite a similar left ventricular function, in comparison with patients with a TTN mutation. Our experimental data suggest that RBM20 mutation carriers may benefit from treatment with an ICa,L blocker to reduce their arrhythmia burden.
Building similarity graph...
Analyzing shared references across papers
Loading...
Maarten M.G. van den Hoogenhof
Heart Failure & Transplant
Abdelaziz Beqqali
British Heart Foundation
Ahmad S. Amin
Electrophysiology
Circulation
Heidelberg University
Amsterdam UMC Location University of Amsterdam
Anna Needs Neuroblastoma Answers
Building similarity graph...
Analyzing shared references across papers
Loading...
Hoogenhof et al. (Thu,) studied this question.
synapsesocial.com/papers/69d56d2f75589c71d767cfe0 — DOI: https://doi.org/10.1161/circulationaha.117.031947